Net Income (TTM) Chart

Historical Net Income (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -67.96M
March 31, 2026 -70.49M
December 31, 2025 -73.60M
September 30, 2025 -79.35M
June 30, 2025 -82.44M
March 31, 2025 -85.87M
December 31, 2024 -86.60M
September 30, 2024 -82.66M
June 30, 2024 -82.42M
March 31, 2024 -83.00M
December 31, 2023 -86.28M
September 30, 2023 -91.00M
Date Value
June 30, 2023 -93.90M
March 31, 2023 -93.28M
December 31, 2022 -92.97M
September 30, 2022 -90.18M
June 30, 2022 -84.58M
March 31, 2022 -78.39M
December 31, 2021 -71.17M
September 30, 2021 -64.37M
June 30, 2021 -54.21M
March 31, 2021 -43.71M
December 31, 2020 -32.78M
September 30, 2020 -24.98M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Champions Oncology, Inc. -1.135M
Medpace Holdings, Inc. 491.50M
Avantor, Inc. -578.00M
Personalis, Inc. -107.18M
Adaptive Biotechnologies Corp. -63.99M